Featured News

  • May 18, 2020

    CARsgen Therapeutics Receives IND Clearance from the US FDA for CT041 CLDN18.2-CAR-T Cells

  • April 27, 2020

    CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma

  • January 06, 2020

    CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs

Press Releases

All

Year

October 26, 2019 ADDITIONAL FORMATS

U.S. Expanded Access Policy

August 30, 2015 ADDITIONAL FORMATS

CARsgen Therapeutics Completes Series A Financing